Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02898818 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vaginal and Oral Microbiome Crosstalk

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Sep 2026 → Sep 2027
See other at-risk trials from Turku University Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Sep 2026 to Sep 2027
    • Study completion pushed from Sep 2027 to Sep 2028
    • Eligibility criteria expanded, about 2 words
  2. Re-verified, no change to tracked fieldsv19
  3. Primary completion date: Sep 2025 to Sep 2026
    • Study completion date: Sep 2026 to Sep 2027
    v18
  4. Site details revisedv17
  5. Primary completion date: Sep 2024 to Sep 2025
    • Study completion date: Sep 2025 to Sep 2026
    • Eligibility criteria expanded, about 13 words
    v16
Show 14 earlier versionsHide 14 earlier versions
  1. 4 versions Re-verified since May 17, 2022, no change to tracked fieldsv12-v15
  2. Primary completion date: Sep 2022 to Sep 2024
    • Study completion date: Sep 2023 to Sep 2025
    v11
  3. Primary completion date: Sep 2021 to Sep 2022v10
  4. 3 versions Re-verified since Dec 13, 2019, no change to tracked fieldsv7-v9
  5. Primary completion date: Sep 2019 to Sep 2021
    • Study completion date: Sep 2021 to Sep 2023
    v6
  6. Re-verified, no change to tracked fieldsv5
  7. Primary completion date: Sep 2018 to Sep 2019v4
  8. Start date changed from estimate of Apr 2017 to Apr 19, 2017v3
  9. Start date: Sep 2016 to Apr 2017
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To study the vaginal and oral microbiome by swab samples. On selected cases, also papa smear will be studied.
Trial Details
NCT Number NCT02898818
Lead Sponsor Turku University Hospital
Collaborators: Oulu University Hospital
Conditions
(from sponsor)		 Healthy, Vaginal Discharge
Related terms Vaginal Discharge
Enrollment 520 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov